A NOVEL APPROACH TO VASCULAR CLOSURE
A new degree of freedom for treating vasculature
Utilizing an active Implant for a super-selective vascular closure
About us
LuSeed provides the interventional vascular world with a game changing approach to short and long-term vascular closure. LuSeed’s technology introduces a proprietary tissue enhancing method designed for controlled vascular remodeling & robust tissue growth.
This first-in-category platform technology positions LuSeed as a potential first mover, in markets involving high demand for safe and precise vascular remodeling tool
The first indication that LuSeed tackles is Cerebral aneurysms, which is a leading cause for haemorrhagic stroke, and is prevalent in 10-15 million Americans.
Aneurysm Ruptures, which are evident in 30% of all cases, may cause a cerebral haemorrhage with 50% survival rate. Current endovascular treatments for Wide Neck Aneurysms, which comprise 40% of all cases and are most difficult to treat, do not present a balanced safety and efficacy profile.
LuSeed provides the interventional vascular world with a game changing approach to short and long-term vascular closure. LuSeed’s technology introduces a proprietary tissue enhancing method designed for controlled vascular remodeling & robust tissue growth.
This first-in-category platform technology positions LuSeed as a potential first mover, in markets involving high demand for safe and precise vascular remodeling tool
The first indication that LuSeed tackles is Cerebral aneurysms.
Providing the interventional vascular world with a novel, game changing approach to vascular closure, by:
- Leveraging the body’s own healing mechanisms to create highly selective vascular remodeling
- Enabling thickening of blood vessel’s wall to the point of full closure
- First indication cerebral aneurysms
Challenges in intrasaccular devices
Difficult implantation procedures
Complex implant selection
Up to 30 different size options
Risk for Protrusion
Release mechanism disturbs flow in the parent artery & causing thrombi
Inaccurate Deployment
High sensitivity to catheter tip location
Long-term risks for patients
50%
non-complete occlusion
11.4%
Retreatment rate
Lifetime Annual follow up
For com-complete occlusion cases
LuSeed intrasaccular device
A Nitinol braided mesh implant containing a composite core wire for visualization
Emitting local electromagnituc waves specifically at the aneurysmal volume
Acute treatment by immediate flow disruption & intensified thrombus Creation. Partition of aneurysm from parent blood vessel
Long term efficacy by enhancement of neo-intimal growth across mesh at neck and mature thrombosis inside the aneurysm
LuSeed’s Device Main benefits
Provides long term efficacy
No protrusion of release mechanism
Agnostic to direction of implantation
5 sizes only
Reduced procedural time
Fit’s in a 0.021” Microcatheter
LuSeed’s Team
Amir Arthur
Co-founder & CEO
Amir Arthur
Co-founder & CEO
Mechanical & Biomedical R&D Engineer
(M.E, Technion)
Vast experience in percutaneous medical devices design with a deep knowledge of long-term vascular implants.
Highly experienced in strategy building & project management.
Nitzan Hirsh
Co-founder & CTO
Nitzan Hirsh
Co-founder & CTO
Mechanical & Biomedical R&D Engineer
(M.E, Technion)
Extensive experience in multidisciplinary medical device systems design, development and management.
Deep knowledge in physical and physiological processes and analysis.
Moshe Miller
Mechanical Engineering Leader
Moshe Miller
- Mechanical R&D leader
- Managed the full life cycle of neurovascular medical products from concept to commercial launching.
- Experience in optimizing design and production processes of commercial products
Dr. Efi Lavie
Active Element Process Development Leader
Dr. Efi Lavie
- Radioisotope production project manager
- Ex. Soreq’s nuclear facility head of Radio pharmacy unit
- Ph.D in Radiochemistry
- Vast experience in radioisotope R&D for the medical device and pharma industries
Shraga Ciner
Mechanical Engineer
Shraga Ciner
- Mechanical R&D and Design Transfer engineer.
- Holds extensive experience in production processes development for minimal invasive medical devices.
Contact Us
- +972 (76) 8899800
-
13 Zarhin St, Building C
4366241 Ra’anana, Israel - info@luseed-vascular.com